Cargando…
555. Utilization of Remdesivir for COVID-19 in the National Veterans Affairs Healthcare System
BACKGROUND: As remdesivir (GS-5734) has become a leading treatment for COVID-19, we sought to assess remdesivir utilization patterns, including utilization of concomitant and supportive therapies, and heterogeneity in treatment approaches. METHODS: Our retrospective cohort study included hospitalize...
Autores principales: | Caffrey, Aisling, Xin Liao, J, Lopes, Vrishali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690682/ http://dx.doi.org/10.1093/ofid/ofab466.753 |
Ejemplares similares
-
557. Trends in Remdesivir Treatment Over the Course of the COVID-19 Pandemic
por: Xin Liao, J, et al.
Publicado: (2021) -
1238. A National Comparison of Antibiograms Between Veterans Affairs Long-Term Care Facilities and Affiliated Hospitals
por: Tolg, Maria-Stephanie, et al.
Publicado: (2018) -
2049. Trends in Antibiotic Use and Antibiotic Resistance among Veterans Affairs Community Living Centers from 2011 to 2017
por: Appaneal, Haley, et al.
Publicado: (2019) -
2012. Trends in Microbiological Culture Collection Across Veterans Affairs Medical Centers and Community Living Centers, 2010 to 2017
por: Appaneal, Haley, et al.
Publicado: (2019) -
Decreasing Antibiotic Resistance Trends Nationally in Gram-Negative Bacteria Across United States Veterans Affairs Medical Centers, 2011–2020
por: Liao, J. Xin, et al.
Publicado: (2023)